Cashing out in biotech in 2022: On-target predictions for AbbVie, Vertex and Genmab Posted on January 1, 2023 By Charlielikes Stock Market Tags:‘cashing, 2022’, abbvie,, and, biotech, for, genmab, in, market, on-target, out, predictions, stock, stock market, vertex